跳至主要内容
临床试验/NCT06911931
NCT06911931招募中不适用

Visual Perception in Schizophrenia: Assessing Predictive Processing in the Earliest Stages of the Visual Cortical Hierarchy

University of Rochester1 个研究点 分布在 1 个国家目标入组 84 人开始时间: 2025年11月3日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
84
试验地点
1
主要终点
mean amplitude of EEG visual response

研究概览

简要总结

This study aims to identify novel markers of psychosis using electroencephalography (EEG).

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Basic Science
盲法
None

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • •All Subjects
  • •Aged 18-65
  • •20/32 visual acuity or better (using in-house optical correction, if necessary)
  • •An ability to speak English well enough to complete study assessments and to consent to the study
  • •Subjects with Schizophrenia-Spectrum Disorder
  • •Meets DSM-5 diagnostic criteria for schizophrenia, schizoaffective disorder, or schizophreniform disorder as confirmed by the Structured Interview for DSM-5 (SCID-5).
  • •Subjects with Bipolar Disorder
  • •Meets DSM-5 diagnostic criteria for bipolar disorder (type I, II, or unspecified) as confirmed by the Structured Interview for DSM-5 (SCID-5).

排除标准

  • •All subjects
  • •Presence of characteristics that could impair one's ability to comprehend the nature of the study, provide informed consent, or understand the assessment questions, including the following:
  • •Subject cannot read and understand the instructions well enough to complete the tasks or cannot provide informed consent.
  • •Intellectual impairment (WRAT-5 score < 70) (at the discretion of experimenter);
  • •Actively intoxicated, as shown via patient self-report or staff report;
  • •Substance use disorder in the past 3 months;
  • •Subject considered high risk for suicidal acts (i.e., active suicidal ideation as determined by clinical interview OR any suicide attempt in 30 days prior to screening);
  • •Subject violence (involving severe/lethal means or violence occurring in prior 6 months) or extreme agitation.
  • •Being in a current manic state
  • •Head injury with loss of consciousness greater than 10 minutes (at the discretion of the experimenter).
  • •Subject has had electroconvulsive therapy (ECT) in the past 8 weeks;
  • •Diagnosed with a neurological condition (tumor, stroke, brain injury) or neurological disorder, including seizure disorders. Diagnosed with pervasive developmental disorder (phone screen or medical records)
  • •Lazy eye or squint or other known ocular pathology
  • •Healthy Control Subjects
  • •Any lifetime psychotic disorder or history of psychiatric hospitalization (self disclosure);
  • •Daily antidepressant, mood stabilizer or antipsychotic medication use in the last 6 months, or benzodiazepine use during the prior 2 days (self-disclosure); iii. First-degree relative(s) with a schizophrenia spectrum disorder (based on subject self-report) or bipolar disorder.
  • •Case-match Control Non-ill Subjects
  • •Any lifetime psychotic disorder (as assessed by SCID/or SSD);
  • •Recurrent depressive episodes or being in a current depressive episode (as assessed by SCID/or SSD)
  • •Persistent threshold psychotic symptoms
  • •History of psychiatric hospitalization;
  • •Daily antidepressant, mood stabilizer or antipsychotic medication use in the last 6 months, or benzodiazepine use during the prior 2 days
  • •First-degree relative(s) with a schizophrenia spectrum disorder (based on subject self-report) or bipolar disorder.
  • •Bipolar Subjects
  • •Persistent threshold psychotic symptoms

研究组 & 干预措施

All participants

Experimental

干预措施: EEG measure of visual processing (Other)

结局指标

主要结局

mean amplitude of EEG visual response

时间窗: Day 1

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Edmund Lalor

Associate Professor

University of Rochester

研究点 (1)

Loading locations...

相似试验